Monocytes, Macrophages, and Metabolic Disease in Atheroscler…
Well Cited
120
Citations112
Refs2019
Year
Search Works
Work Details
- DOI 10.3389/fphar.2019.00666
- PMID https://pubmed.ncbi.nlm.nih.gov/31249530
- OpenAlex ID W2951883591
- Type Article
- Language EN
- Published 13 Jun 2019
- Volume 10
- Pages 666
- Source Frontiers in Pharmacology
- Publisher Frontiers Media
- FWCI 4.90
- Countries 2
- Institutions 2
- Added 10 Oct 2025
- Updated 08 Oct 2026
External Links
MENU
0
Monocytes, Macrophages, and Metabolic Disease in Atherosclerosis
Article 2019 EN Gold
Atherosclerotic cardiovascular disease (CVD) is a lipid-driven chronic inflammatory disease, in which macrophages are responsible for taking up these lipids and driving disease progression. Over the years, we and others have uncovered key pathways that regulate macrophage number/function and identified how metabolic disorders such as diabetes and obesity, which are common risk factors for CVD, exa…
120
Citations
112
References
5
Authors
4.90
FWCI
Citations by Year
Last 8 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
5 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Michelle Flynn Corresponding | Baker Heart and Diabetes Insti… (AU) | — |
| 2 | Gerard Pernes | Baker Heart and Diabetes Insti… (AU) | |
| 3 | Man K.S. Lee | Baker Heart and Diabetes Insti… (AU) | — |
| 4 | Prabhakara R. Nagareddy | University of Alabama at Birmi… (US) | |
| 5 | Andrew James Murphy | Baker Heart and Diabetes Insti… (AU) |
Related Works
10Data: OpenAlex